Compare MYNZ & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYNZ | MTR |
|---|---|---|
| Founded | 2021 | 1979 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 8.8M |
| IPO Year | 2021 | N/A |
| Metric | MYNZ | MTR |
|---|---|---|
| Price | $1.23 | $4.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 197.9K | 3.8K |
| Earning Date | 12-29-2025 | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $659,935.00 | $623,288.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | ★ N/A | $21.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $4.29 |
| 52 Week High | $8.20 | $10.42 |
| Indicator | MYNZ | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 40.01 |
| Support Level | $1.00 | $4.60 |
| Resistance Level | $1.15 | $4.95 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 87.76 | 25.00 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.